PA
SMMT icon

Profund Advisors’s Summit Therapeutics SMMT Stock Holding History

Profund Advisors’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.14M Buy
112,926
+9,165
+9% +$148K 0.08% 184
2025
Q4 		$1.81M Buy
103,761
+33,828
+48% +$636K 0.06% 235
2025
Q3 		$1.44M Buy
69,933
+30,293
+76% +$735K 0.05% 253
2025
Q2 		$844K Sell
39,640
-7,544
-16% -$172K 0.03% 334
2025
Q1 		$910K Sell
47,184
-12,093
-20% -$243K 0.04% 312
2024
Q4 		$1.06M Buy
59,277
+36,958
+166% +$716K 0.04% 286
2024
Q3 		$489K Sell
22,319
-8,883
-28% -$124K 0.02% 543
2024
Q2 		$243K Sell
31,202
-69,813
-69% -$377K 0.01% 853
2024
Q1 		$418K Buy
+101,015
New +$402K 0.02% 665

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return